The power of continuous glucose monitoring system (CGMS) technology to profile glycemic patterns throughout a 24-h period has benefited the care of individuals with diabetes mellitus for over 10 years. Recently, this technology has been utilized to better understand glucose patterns in pregnancy, especially as they relate to abnormal fetal growth given that adiposity at birth is associated with increased risks for childhood obesity and metabolic syndrome. However, the lack of a standardized approach to defining glucose measures associated with maternal outcomes and fetal growth has greatly limited comparison and pooling of CGMS data among pregnancy trials, hindering our ability to take advantage of the enormous amount of data available to explore these relationships. The purpose of this article is to offer a methodical approach to the identification and extraction of CGMS-derived glucose variables for the characterization of glycemic profiles in pregnant women, particularly focusing on women with gestational diabetes or obesity who are at risk for abnormal fetal growth. A review of the properties of CGMS data and examples of how CGMS data in pregnancy have been reported to date are included. We further define several pregnancy-relevant, CGMS-derived glucose variables and directly apply them to unpublished data to illustrate how these measures might be utilized. This approach offers one possible standardized method to define and analyze these time-sensitive glucose measures to facilitate comparisons among studies and to increase our understanding of how glycemic profiles contribute to excess infant adiposity in pregnant women with and without diabetes.
Get full access to this article
View all access options for this article.
References
1.
KitzmillerJL, BlockJM, BrownFM, CatalanoPM, ConwayDL, CoustanDR, GundersonEP, HermanWH, HoffmanLD, InturrisiM, JovanovicLB, KjosSI, KnoppRH, MontoroMN, OgataES, ParamsothyP, ReaderDM, RosennBM, ThomasAM, KirkmanMS. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care, 2008; 31:1060–1079.
2.
de VecianaM, MajorCA, MorganMA, AsratT, TooheyJS, LienJM, EvansAT. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med, 1995; 333:1237–1241.
3.
HernandezTL, FriedmanJE, van PeltRE, BarbourLA. Patterns of glycemia in normal pregnancy: should the current therapeutic targets be challenged?Diabetes Care, 2011; 34:1660–1668.
4.
The HAPO Study Cooperative Research Group:. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes, 2009; 58:453–459.
BoneyCM, VermaA, TuckerR, VohrBR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics, 2005; 115:e290–e296.
7.
HarmonKA, GerardL, JensenDR, KealeyEH, HernandezTL, ReeceMS, BarbourLA, BessesenDH. Continuous glucose profiles in obese and normal-weight pregnant women on a controlled diet: metabolic determinants of fetal growth. Diabetes Care, 2011; 34:2198–2204.
8.
HernandezTL. Patterns of Glycemia During the Insulin Resistance of Pregnancy: Obesity, Gestational Diabetes and Relationship to Neonatal Adiposity [Ph.D. thesis]Denver: University of Colorado, 2009.
9.
HernandezTL, van PeltRE, JensenDR, ReeceMS, KahnB, FriedmanJE, BarbourLA. Glycemic patterns that predict neonatal adiposity in lean and obese pregnant women on fixed diets [abstract]Diabetes, 2009; 58:A640.
10.
YogevY, Ben HaroushA, ChenR, RosennB, HodM, LangerO. Diurnal glycemic profile in obese and normal weight nondiabetic pregnant women. Am J Obstet Gynecol, 2004; 191:949–953.
11.
RodbardD. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther, 2009; 11,Suppl 1:S55–S67.
RodbardD, BaileyT, JovanovicL, ZisserH, KaplanR, GargSK. Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. Diabetes Technol Ther, 2009; 11:717–723.
15.
VoelmleM, RitchieP, NaikR, GargS. Improved A1C values with no increase in hypoglycemia in pregnant women with Type 1 diabetes using real-time continuous home glucose monitors [abstract]Diabetes, 2008; 57:A117.
16.
SacksDB, BrunsDE, GoldsteinDE, MaclarenNK, McDonaldJM, ParrottM. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem, 2002; 48:436–472.
Consensus statement on self-monitoring of blood glucose. Diabetes Care, 1987; 10:95–99.
19.
American Diabetes Association:. Standards of medical care in diabetes—2008. Diabetes Care, 2008; 31,Suppl 1:S12–S54.
20.
KovatchevB, AndersonS, HeinemannL, ClarkeW. Comparison of the numerical and clinical accuracy of four continuous glucose monitors. Diabetes Care, 2008; 31:1160–1164.
21.
GrossTM, BodeBW, EinhornD, KayneDM, ReedJH, WhiteNH, MastrototaroJJ. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther, 2000; 2:49–56.
22.
GrossTM, TerVA. Continuous glucose monitoring in previously unstudied population subgroups. Diabetes Technol Ther, 2000; 2,Suppl 1:S27–S34.
23.
KovatchevB, BretonM, ClarkeW. Analytical methods for the retrieval and interpretation of continuous glucose monitoring data in diabetes. Methods Enzymol, 2009; 454:69–86.
24.
ChenR, YogevY, Ben HaroushA, JovanovicL, HodM, PhillipM. Continuous glucose monitoring for the evaluation and improved control of gestational diabetes mellitus. J Matern Fetal Neonatal Med, 2003; 14:256–260.
25.
SiegmundT, RadNT, RitterathC, SiebertG, HenrichW, BuhlingKJ. Longitudinal changes in the continuous glucose profile measured by the CGMS in healthy pregnant women and determination of cut-off values. Eur J Obstet Gynecol Reprod Biol, 2008; 139:46–52.
26.
Ben HaroushA, YogevY, ChenR, RosennB, HodM, LangerO. The postprandial glucose profile in the diabetic pregnancy. Am J Obstet Gynecol, 2004; 191:576–581.
27.
CyprykK, Pertynska-MarczewskaM, SzymczakW, WilcynskiJ, LewinskiA. Evaluation of metabolic control in women with gestational diabetes mellitus by the continuous glucose monitoring system: a pilot study. Endocr Pract, 2006; 12:245–250.
28.
BuhlingKJ, WinkelT, WolfC, KurzidimB, MahmoudiM, WohlfarthK, WascherC, SchinkT, DudenhausenJW. Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System (CGMS)J Perinat Med, 2005; 33:125–131.
29.
PorterH, LookinlandS, BelfortMA. Evaluation of a new real-time blood continuous glucose monitoring system in pregnant women without gestational diabetes. A pilot study. J Perinat Neonatal Nurs, 2004; 18:93–102.
30.
BuhlingKJ, KurzidimB, WolfC, WohlfarthK, MahmoudiM, WascherC, SiebertG, DudenhausenJW. Introductory experience with the continuous glucose monitoring system (CGMS; Medtronic Minimed) in detecting hyperglycemia by comparing the self-monitoring of blood glucose (SMBG) in non-pregnant women and in pregnant women with impaired glucose tolerance and gestational diabetes. Exp Clin Endocrinol Diabetes, 2004; 112:556–560.
31.
AdolfssonP, NilssonS, LindbladB. Continuous glucose monitoring system during physical exercise in adolescents with type 1 diabetes. Acta Paediatr, 2011; 100:1603–1609.
32.
WillmanSP, LevenoKJ, GuzickDS, WilliamsML, WhalleyPJ. Glucose threshold for macrosomia in pregnancy complicated by diabetes. Am J Obstet Gynecol, 1986; 154:470–475.
33.
MetzgerBE, BuchananTA, CoustanD, de LeivaA, DungerDB, HaddenDR, HodM, KitzmillerJL, KjosSL, OatsJN, PettittDJ, SacksDA, ZoupasC. Summary, recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care, 2007; 30,Suppl 2:S251–S260Erratum in Diabetes Care 2007;30:3154.
34.
LangerO, LevyJ, BrustmanL, AnyaegbunamA, MerkatzR, DivonM. Glycemic control in gestational diabetes mellitus—how tight is tight enough: small for gestational age versus large for gestational age?Am J Obstet Gynecol, 1989; 161:646–653.
35.
SacksDA, ChenW, Wolde-TsadikG, BuchananTA. When is fasting really fasting? The influence of time of day, interval after a meal, and maternal body mass on maternal glycemia in gestational diabetes. Am J Obstet Gynecol, 1999; 181:904–911.
36.
PedersenJ. Course of diabetes during pregnancy. Acta Endocrinol (Copenh), 1952; 9:342–364.
37.
HayWWJr. Placental-fetal glucose exchange and fetal glucose metabolism. Trans Am Clin Climatol Assoc, 2006; 117:321–339.
38.
PotteigerJA, JacobsenDJ, DonnellyJE. A comparison of methods for analyzing glucose and insulin areas under the curve following nine months of exercise in overweight adults. Int J Obes Relat Metab Disord, 2002; 26:87–89.
39.
McGarraughG. The chemistry of commercial continuous glucose monitors. Diabetes Technol Ther, 2009; 11,Suppl 1:S-17–S-24.
40.
MetzgerBE, PhelpsRL, FreinkelN, NavickasIA. Effects of gestational diabetes on diurnal profiles of plasma glucose, lipids, and individual amino acids. Diabetes Care, 1980; 3:402–409.
41.
PhelpsRL, MetzgerBE, FreinkelN. Carbohydrate metabolism in pregnancy. XVII. Diurnal profiles of plasma glucose, insulin, free fatty acids, triglycerides, cholesterol, and individual amino acids in late normal pregnancy. Am J Obstet Gynecol, 1981; 140:730–736.
42.
ZijlstraE, HeiseT, NosekL, HeinemannL, HeckermannS. Continuous glucose monitoring: quality of hypoglycaemia detection. Diabetes Obes Metab, 2012September13[Epub ahead of print]10.1111/dom.12001.
43.
SivanE, WeiszB, HomkoCJ, ReeceEA, SchiffE. One or two hours postprandial glucose measurements: are they the same?Am J Obstet Gynecol, 2001; 185:604–607.
44.
Jovanovic-PetersonL, PetersonCM, ReedGF, MetzgerBE, MillsJL, KnoppRH, AaronsJH. Maternal postprandial glucose levels, infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development—Diabetes in Early Pregnancy Study. Am J Obstet Gynecol, 1991; 164:103–111.
